Medical technology company Teleflex (NYSE:TFX) announced better-than-expected revenue in Q2 CY2025, with sales up 2.3% year on year to $780.9 million. Its non-GAAP profit of $3.73 per share was 10.8% ...

This medical technology company supplies single-use devices for critical care and surgery to hospitals and healthcare providers worldwide.

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices WAYNE, Pa., Feb. 27, 2025 ...

Ratings for Teleflex (NYSE:TFX) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

Fintel reports that on January 27, 2026, Needham upgraded their outlook for Teleflex (NYSE:TFX) from Hold to Buy. Analyst ...

What recent performance says about Teleflex Teleflex (TFX) has drawn attention after a mixed stretch, with the stock up about ...

WAYNE, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has published its 2024 Global Impact Report. The ...

The latest announcement is out from Teleflex ( (TFX) ).

In early January 2026, Teleflex announced the past departure of Chairman, President and CEO Liam Kelly, appointed long-time director Stuart Randle as Interim President and CEO, named Dr. Stephen ...

Look here for a clue. There's no foolproof way to know the future for Teleflex (NYSE: TFX) or any other company. However, certain clues may help you see potential stumbles before they happen -- and ...